Study on the expression of endostatin and CD34 endothelial progenitor cells (EPCs) and its significance in endometrial adenocarcinoma and uterus myoma

Li Min,Ma Guojuan,Feng Jing,Meng Huiyan,Zhang Wenhui,Li Yajing
DOI: https://doi.org/10.3969/j.issn.1008-8849.2013.20.004
2013-01-01
Abstract:Objective It is to investigate the expression of endostatin and endothelial progenitor cells(EPCs) and its significance in endometrial adenocarcinoma and uterus myoma.Methods The expression of endostatin and EPCs in 24 cases of normal endometrium,68 cases of uterus myoma and 92 cases of endometrial adenocarcinoma were examined by immunohistochemisry staining,and the correlations of them with the clinical pathological parameters and progression of disease with adenocarcinoma endometrial were analyzed.Results ①There was no significant difference in the expression of endostatin protein between normal endometrium and uterus myoma,but the expression of endostatin protein in endometrial adenocarcinoma was markedly higher than that in uterus myoma and normal endometrium.②There was significant difference in the expression of EPCs between endometrial adenocarcinoma and normal endometrium or uterus myoma.③The levels of endostatin protein expression in adenocarcinoma endometrial was significantly associated with clinical stage.④The levels of EPCs in adenocarcinoma endometrial was significantly associated with clinical stage,histological grades,lymph node metastasis and myometrial invasion.⑤The expression of endostatin was significantly associated with EPCs.Conclusion The expression of endostatin protein and EPCs may has a relationship with the development of endometrial adenocarcinoma and prognosis of the patients.
What problem does this paper attempt to address?